Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients.

Cell Death Discov · 2016 · PMC5045963 · PMID 27752361

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Conversely, an increasing trend, even if not significant, was observed in the percentage of activated MDICs (CD11b + CD14 + CD15 + ) in both groups of patients ( Figures 3b and 4 ).

also in 63,971 other papers

showed a trendno p-value reported

The latter group of patients, conversely, showed a trend to increase IL8 and IFNγ levels, even though without reaching statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.